The NHS has agreed to pay for the cannabis medicine of a severely epileptic boy nearly two years after his case helped persuade the government to legalise the treatment.
The health service announced yesterday that it would fund Billy Caldwell’s cannabis medicine, in a move that is likely to allow parents of other epileptic children to obtain financial support for similar treatments.
The decision is the first time the NHS has agreed to pay for a prescription for an unlicensed cannabis medicine for a child since the law changed on November 1, 2018.
Until now, the medical establishment refused to prescribe cannabis medicines on the NHS until their efficacy had been proven in clinical trials.
However, the pharmaceutical industry is resistant to investing in trials